tradingkey.logo

Abbott falls after Q4 revenue misses estimates

ReutersJan 22, 2026 12:46 PM

Shares of medical device maker Abbott Laboratories ABT.N fall 7% to $112.54 premarket

Co posts Q4 revenue of $11.46 billion, missing analysts' estimate of $11.8 billion, according to data compiled by LSEG

Forecasts 2026 adj. profit in the range of $5.55 to $5.80 per share, compared with analysts' estimate of $5.68 per share

Reports Q4 adj. profit of $1.50 per share, in line with estimates

ABT stock climbed 10.7% in 2025

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI